Replimune Group REPL Income Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $188.4M+7.7% | $174.96M+38.3% | $126.53M+59.1% | ||
| $73.23M+22.4% | $59.81M+18.3% | $50.55M+30.4% | ||
| $261.63M+11.4% | $234.78M+32.6% | $177.08M+49.7% | ||
| $261.63M+11.4% | $234.78M+32.6% | $177.08M+49.7% | ||
| -$261.63M-11.4% | -$234.78M-32.6% | -$177.08M-49.7% | ||
| $5.78M+28.4% | $4.5M+129% | $1.96M+76.1% | ||
| $21.12M-9.6% | $23.36M+133% | $10.01M+2,466% | ||
| $14.8M-23.7% | $19.39M+529% | $3.08M+1,009% | ||
| -$246.83M-14.6% | -$215.39M-23.8% | -$174M-47.4% | ||
| —— | —— | $288K— | ||
| -$247.3M-14.6% | -$215.79M-23.8% | -$174.28M-47.7% | ||
| -$3.07+5.2% | -$3.24-8.0% | -$3.00-32.7% | ||
| -$3.07+5.2% | -$3.24-8.0% | -$3.00-32.7% | ||
| 311.8M+17.2% | 266.2M+18.3% | 225.1M+7.9% | ||
| 311.8M+17.2% | 266.2M+18.3% | 225.1M+7.9% | ||
| $21.12M-9.6% | $23.36M+133% | $10.01M+2,466% | ||
| $5.78M+28.4% | $4.5M+129% | $1.96M— | ||
| —— | —— | -$5.68M-436% | ||
| $1.77M-7.7% | $1.92M-34.1% | $2.91M-8.1% | ||
| -$261.63M-11.4% | -$234.78M-32.6% | -$177.08M-49.7% | ||
| -$258.15M-11.2% | -$232.05M-32.9% | -$174.63M-50.3% | ||
| -$258.15M-11.2% | -$232.05M-32.9% | -$174.63M-50.3% | ||
| -$261.63M-11.4% | -$234.78M-32.6% | -$177.08M-49.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Replimune Group profitable?
- Replimune Group is not currently profitable: it reported a net loss of $314.9M over the trailing twelve months.
- What is Replimune Group's earnings per share?
- Replimune Group's diluted EPS over the trailing twelve months is $-3.44.
- Where does Replimune Group's income statement data come from?
- Every line is extracted from Replimune Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.